Derakhshanian, 290 patient vitamin D sufficiency study: 45% lower mortality [p=0.05], 42% lower ventilation [p=0.09], and 37% lower ICU admission [p=0.04] https://c19p.org/derakhshanian
copied to clipboard
The predictive power of serum vitamin D for poor outcomes in COVID-19 patients
et al., Food Science & Nutrition, doi:10.1002/fsn3.2591
Retrospective 290 hospitalized patients in Iran, showing higher mortality with vitamin D deficiency.
|
risk of death, 44.8% lower, RR 0.55, p = 0.046, high D levels 148, low D levels 142, odds ratio converted to relative risk, control prevalance approximated with overall prevalence.
|
|
risk of mechanical ventilation, 41.7% lower, RR 0.58, p = 0.09, high D levels 148, low D levels 142, odds ratio converted to relative risk, control prevalance approximated with overall prevalence.
|
|
risk of ICU admission, 37.3% lower, RR 0.63, p = 0.04, high D levels 148, low D levels 142, odds ratio converted to relative risk, control prevalance approximated with overall prevalence.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Derakhshanian et al., 9/19/2021, retrospective, Iran, Middle East, peer-reviewed, 11 authors.
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.